Evidence map›Paper›PMID 33952632›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2021

Tacrolimus Protects against Age-Associated Microstructural Changes in the Beagle Brain.

Hamsanandini Radhakrishnan, Margo F Ubele, Stephanie M Krumholz, Kathy Boaz, Jennifer L Mefford, Erin Denhart Jones, Beverly Meacham, Jeffrey Smiley, László G Puskás, David K Powell and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Age-Related Brain Atrophy and the Positive Effects of Behavioral Enrichment in Middle-Aged Beagles.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  8. Article
  9. Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Extensive Connections of the Canine Olfactory Pathway Revealed by Tractography and Dissection.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Hamsanandini RadhakrishnanMathematical, Computational and Systems Biology, University of California, Irvine, Irvine, California 92697.
Margo F UbeleSanders Brown Center on Aging, Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, Kentucky 40506.
Stephanie M KrumholzSanders Brown Center on Aging, Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, Kentucky 40506.
Kathy BoazSanders Brown Center on Aging, Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, Kentucky 40506.
Jennifer L MeffordDivision of Laboratory Animal Resources, University of Kentucky, Lexington, Kentucky 40506.
Erin Denhart JonesDivision of Laboratory Animal Resources, University of Kentucky, Lexington, Kentucky 40506.
Beverly MeachamMagnetic Resonance Imaging and Spectroscopy Center, University of Kentucky, Lexington, Kentucky 40506.
Jeffrey SmileyDivision of Laboratory Animal Resources, University of Kentucky, Lexington, Kentucky 40506.
László G PuskásAperus Pharma, H-6726, Szeged, Hungary.
David K PowellMagnetic Resonance Imaging and Spectroscopy Center, University of Kentucky, Lexington, Kentucky 40506.
Christopher M NorrisSanders Brown Center on Aging, Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, Kentucky 40506.
Craig E L StarkMathematical, Computational and Systems Biology, University of California, Irvine, Irvine, California 92697.
Elizabeth HeadDepartment of Pathology & Laboratory Medicine, University of California, Irvine, Irvine, California 92697 heade@uci.edu.
University of Kentucky · USUniversity of California, Irvine · US

Funding

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's diseaseR01AG056998 · NIA · UNIVERSITY OF KENTUCKY · PI Elizabeth Head, Christopher Mark Norris · 2017 to 2026
$5.3M
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's diseaseRF1AG056998 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI HEAD, ELIZABETH, NORRIS, CHRISTOPHER MARK · 2022 to 2022
$4.1M
NIA NIH HHS R01 AG056998NIA NIH HHS RF1 AG056998
6 · The paper itself

Abstract

The overexpression of calcineurin leads to astrocyte hyperactivation, neuronal death, and inflammation, which are characteristics often associated with pathologic aging and Alzheimer's disease. In this study, we tested the hypothesis that tacrolimus, a calcineurin inhibitor, prevents age-associated microstructural atrophy, which we measured using higher-order diffusion MRI, in the middle-aged beagle brain (

Indexed as

AgingAnimalsAtrophyBrainCalcineurin InhibitorsDogsFemaleMaleTacrolimusCalcineurin InhibitorsTacrolimusagingAlzheimer's diseasecalcineurincaninediffusion-weighted imagingneuroinflammation

Identifiers

PMID33952632
PMCPMC8197636
OpenAlexW3158921386

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.